|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01828 FWD
Nominal 
() | 2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | |
| Insurance Revenue | 2,724,000 | -1.161% | 2,756,000 | 2,408,000 |
| Interest Income | 1,185,000 | 2.243% | 1,159,000 | 1,011,000 |
| Turnover | -- | -- | -- | -- |
| Gross Premium Income | -- | -- | -- | -- |
| Net Premium Income | -- | -- | -- | -- |
| Investment Income/(Loss) | 93,000 | -- | (791,000) | (999,000) |
| Net Realised Gains/(Losses) on Assets | -- | -- | -- | -- |
| Net Fair Value Gains / (Losses) on Assets | -- | -- | -- | -- |
| Other Income/(Loss) | 36,000 | -43.750% | 64,000 | 38,000 |
| Total Revenues | 4,038,000 | 26.662% | 3,188,000 | 2,458,000 |
| Insurance Service Expenses | (2,012,000) | 1.156% | (1,989,000) | (1,817,000) |
| Net Expenses from Reinsurance Contracts | (42,000) | -52.273% | (88,000) | (146,000) |
| Net Finance (Expenses)/Income from Insurance Contracts | (1,051,000) | 5.522% | (996,000) | 86,000 |
| Net Finance (Expenses)/Income from Reinsurance Contracts | 31,000 | 3000.000% | 1,000 | (23,000) |
| Net Impairment Loss | (16,000) | 77.778% | (9,000) | (29,000) |
| Other Expenses | (800,000) | -11.210% | (901,000) | (815,000) |
| Other Non-operating Items | -- | -- | -- | -- |
| Share of results of Associates & JCEs | 36,000 | -- | (20,000) | 2,000 |
| Profit / (Loss) before Taxation | 184,000 | -- | (814,000) | (284,000) |
| Taxation | (174,000) | -- | 97,000 | (36,000) |
| Profit / (Loss) for Discontinued Operations | -- | -- | -- | -- |
| Non-controlling Interests | 14,000 | 1300.000% | 1,000 | 101,000 |
| Others | (102,000) | -7.273% | (110,000) | (83,000) |
| Profit/ (Loss) Attributable to Shareholders | (78,000) | -90.557% | (826,000) | (302,000) |
| 2024/12 - Final USD(K$) | %Chg (Compare to Final) | 2023/12 USD(K$) | 2022/12 USD(K$) | |
| Depreciation & Amortisation | 105,000 | 0.000% | 105,000 | 95,000 |
| Directors' Emoluments | 6,121 | -10.139% | 6,811 | 6,474 |
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| Auditor's Opinion Status | Unqualified | -- | Unqualified | Unqualified |
Market Valuation Indicators
| 2024/12 - Final | %Chg (Compare to Final) | 2023/12 | 2022/12 | |
| EPS (cts) | -- | -- | -- | -- |
| DPS (cts) | -- | -- | -- | -- |
| Dividend Payout Ratio (%) | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- |
| NBV per share ($) | -- | -- | -- | -- |
| Remarks: | Real time quote last updated: 27/06/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | USD -78,000,000 |
| %Change | -90.557% |
| EPS / (LPS) | USD -- |
| NBV Per Share ($) | USD -- |